Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder

Condition:   Post-transplant Lymphoproliferative Disorder Interventions:   Drug: Rituximab;   Drug: Acalabrutinib;   Diagnostic Test: CT scans Sponsor:   Deepa Jagadeesh Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials